Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
NCT01326104
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Medulloblastoma
Neuroectodermal Tumor
Interventions
BIOLOGICAL:
TTRNA-xALT
BIOLOGICAL:
TTRNA-DCs
Sponsor
University of Florida
Collaborators
[object Object]